SAILIFE — SAI Life Sciences Share Price
Last trade - 00:00- IN₹141.73bn
- IN₹149.53bn
- IN₹14.65bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 56.43 | ||
| PEG Ratio (f) | 1.48 | ||
| EPS Growth (f) | 61.29% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 13.71 | ||
| Price to Tang. Book | 13.87 | ||
| Price to Free Cashflow | 936.22 | ||
| Price to Sales | 9.22 | ||
| EV to EBITDA | 40.45 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.81% | ||
| Return on Equity | 14.36% | ||
| Operating Margin | 15.54% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | 8,695.93 | 12,171.39 | 14,651.78 | 16,381.46 | 19,319.02 | 29.8% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +701.24 | +89.8 | +61.29 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 25th, 1999
- Public Since
- December 18th, 2024
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 208,414,389
- Address
- 8-2-120/86/9/B Luxor Park, HYDERABAD, 500032
- Web
- https://www.sailife.com/
- Phone
- +91 4068156000
- Auditors
- Deloitte Haskins & Sells LLP
Similar to SAILIFE
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 23:02 UTC, shares in SAI Life Sciences are trading at IN₹687.70. This share price information is delayed by 15 minutes.
Shares in SAI Life Sciences last closed at IN₹687.70 and the price had moved by over the past 365 days. In terms of relative price strength the SAI Life Sciences share price has matched the S&P BSE 100 Index by over the past year.
The overall consensus recommendation for SAI Life Sciences is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSAI Life Sciences does not currently pay a dividend.
SAI Life Sciences does not currently pay a dividend.
SAI Life Sciences does not currently pay a dividend.
To buy shares in SAI Life Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹687.70, shares in SAI Life Sciences had a market capitalisation of IN₹141.73bn.
Here are the trading details for SAI Life Sciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SAILIFE
Based on an overall assessment of its quality, value and momentum SAI Life Sciences is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in SAI Life Sciences is IN₹770.24. That is 12% above the last closing price of IN₹687.70.
Analysts covering SAI Life Sciences currently have a consensus Earnings Per Share (EPS) forecast of IN₹7.56 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SAI Life Sciences. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹687.70, shares in SAI Life Sciences were trading -3.31% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SAI Life Sciences PE ratio based on its reported earnings over the past 12 months is 56.43. The shares last closed at IN₹687.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on SAI Life Sciences' directors